Page last updated: 2024-09-04

ezetimibe and triolein

ezetimibe has been researched along with triolein in 3 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (triolein)	Trials (triolein)	Recent Studies (post-2010) (triolein)
2,484	563	1,465	1,692	36	161

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Compton, DS; Davis, HR; Farley, C; Hoos, L; van Heek, M	1
Inagaki, M; Ishigami, M; Kawase, R; Komuro, I; Masuda, D; Matsuyama, A; Nakagawa-Toyama, Y; Nakaoka, H; Nakatani, K; Nishida, M; Ohama, T; Sandoval, JC; Tochino, Y; Tsubakio-Yamamoto, K; Yamashita, S; Yuasa-Kawase, M	1
Machado Cesar, LA; Mangili, LC; Mangili, OC; Maranhão, RC; Mesquita, CH; Moron Gagliardi, AC; Santos, RD; Schaefer, EJ; Tanaka, A	1

Trials

1 trial(s) available for ezetimibe and triolein

Article	Year
Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 2014, Volume: 233, Issue:1 Topics: Aged; Azetidines; Cholesterol Esters; Chylomicron Remnants; Chylomicrons; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Kinetics; Male; Middle Aged; Simvastatin; Triglycerides; Triolein	2014

Article

Year

Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects.

Atherosclerosis, 2014, Volume: 233, Issue:1

Topics: Aged; Azetidines; Cholesterol Esters; Chylomicron Remnants; Chylomicrons; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Kinetics; Male; Middle Aged; Simvastatin; Triglycerides; Triolein

2014

Other Studies

2 other study(ies) available for ezetimibe and triolein

Article	Year
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. British journal of pharmacology, 2001, Volume: 134, Issue:2 Topics: Animals; Anticholesteremic Agents; Azetidines; Biliary Tract Surgical Procedures; Carbon Radioisotopes; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Cricetinae; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ezetimibe; Intestinal Absorption; Intestinal Mucosa; Liver; Male; Mesocricetus; Pancreas; Progesterone; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Triolein; Tritium; Vitamin A; Vitamin D	2001
Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia. Journal of atherosclerosis and thrombosis, 2010, Sep-30, Volume: 17, Issue:9 Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-48; Azetidines; Base Sequence; CD36 Antigens; Chylomicrons; Disease Models, Animal; DNA Primers; Ezetimibe; Fatty Acid Transport Proteins; Fatty Acid-Binding Proteins; Hypertriglyceridemia; Intestinal Absorption; Lipoproteins, VLDL; Lymph; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Postprandial Period; RNA, Messenger; Triglycerides; Triolein	2010

Article

Year

Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.

British journal of pharmacology, 2001, Volume: 134, Issue:2

Topics: Animals; Anticholesteremic Agents; Azetidines; Biliary Tract Surgical Procedures; Carbon Radioisotopes; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Cricetinae; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ezetimibe; Intestinal Absorption; Intestinal Mucosa; Liver; Male; Mesocricetus; Pancreas; Progesterone; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Triolein; Tritium; Vitamin A; Vitamin D

2001

Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.

Journal of atherosclerosis and thrombosis, 2010, Sep-30, Volume: 17, Issue:9

Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-48; Azetidines; Base Sequence; CD36 Antigens; Chylomicrons; Disease Models, Animal; DNA Primers; Ezetimibe; Fatty Acid Transport Proteins; Fatty Acid-Binding Proteins; Hypertriglyceridemia; Intestinal Absorption; Lipoproteins, VLDL; Lymph; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Postprandial Period; RNA, Messenger; Triglycerides; Triolein

2010